Resmetirom Tablet Franchise in Ahmedabad

Lipid & Liver Care Tablet Supplier in Mumbai

NAFLD Medicine Distributor in Delhi

Metabolic Health Pharma Franchise in Bangalore

Resmetirom Tablet Stockist in Hyderabad
Lipid & Liver Care Tablet Manufacturer & Exporter in Chandigarh

Home/Products /resmetirom-80mg-tablet

Restripe 80 Tablet

Composition : Resmetirom (80mg) Tablet

Dosage Form : Tablet

Packaging Type : in a Bottle

Packaging : 30 Tablets

Price : ₹0/-

Please Contact For Best Price

Restripe 80 Tablet contains Resmetirom 80mg, a high-potency therapy for lipid and liver health management. It effectively reduces liver fat, improves lipid metabolism, and supports liver function, making it ideal for patients with NAFLD and metabolic disorders.

Prescribers trust this tablet for its clinical efficacy and safety, providing patients with consistent liver and metabolic health benefits. Improved outcomes lead to better adherence and repeat prescriptions, ensuring steady demand.

For franchise partners, Restripe 80 Tablet is a premium product in the liver and metabolic care segment, offering strong market potential. Its advanced therapeutic profile and prescriber confidence make it a profitable addition to specialty portfolios, enhancing business reach.

With the rising prevalence of NAFLD and lipid-related disorders, Restripe 80 Tablet provides sustainable sales opportunities, helping partners establish a strong presence in the liver and metabolic care segment.

Read More

About the Product

Restripe 80 Tablet contains Resmetirom 80mg, a high-potency therapy for lipid and liver health management. It effectively reduces liver fat, improves lipid metabolism, and supports liver function, making it ideal for patients with NAFLD and metabolic disorders.

Prescribers trust this tablet for its clinical efficacy and safety, providing patients with consistent liver and metabolic health benefits. Improved outcomes lead to better adherence and repeat prescriptions, ensuring steady demand.

For franchise partners, Restripe 80 Tablet is a premium product in the liver and metabolic care segment, offering strong market potential. Its advanced therapeutic profile and prescriber confidence make it a profitable addition to specialty portfolios, enhancing business reach.

With the rising prevalence of NAFLD and lipid-related disorders, Restripe 80 Tablet provides sustainable sales opportunities, helping partners establish a strong presence in the liver and metabolic care segment.

Common side effects may include headache, fatigue, nausea, diarrhea, or mild transient increases in liver enzymes. Some patients may experience palpitations, insomnia, or gastrointestinal discomfort. Severe or persistent symptoms should be reported immediately to a healthcare professional.

Restripe 80 Tablet is indicated for the treatment of non-alcoholic steatohepatitis (NASH) and associated dyslipidemia in adults. It helps reduce liver fat content, improve lipid metabolism, and support liver function in patients at risk of progressive liver disease.

Restripe 80 Tablet should be taken as prescribed and not used in patients with severe liver dysfunction or hypersensitivity to Resmetirom. Regular monitoring of liver function tests and lipid profile is recommended during therapy. Inform your doctor about other medications or underlying health conditions before starting treatment.

Store Restripe 80 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date indicated on the pack.

Get in Touch